NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

If I had to guess LP is doing everything with 2 end goals in mind: RA approval and physician acceptance.

The NYAS presentation was to get the info in front of influential doctors and decision makers in a very small circle of neurosurgeons that deal with GBM.

Once RA approval(s) happen and revenue starts flowing the share price will fix itself. Before that point you would have to engage in games to counter nefarious forces in order to prop up the short term share price, and these games do nothing to help with physician acceptance and RA approval(s).

LP is playing the long game and the only game that matters imo, RA approvals and physician acceptance. Per my impressions with a company rep from a few months ago:

- Long difficult trial and wants to get support of community
- Want to lay the groundwork for a very supportive environment
- They don’t see this as laying the groundwork for just DCVax-L for GBM, but for the entire pipeline
- Gain acceptance of clinical community, maybe by impressive results or publication, that creates an environment that physicians know, start to utilize and believe in it
- This is a lot more than just TLD, but how the world looks at solid tumors on all levels
- All solid tumors, think what that means if you lay the correct foundation
- Share price is not an indicator of how well the company is doing
- NWBO won’t do things to hype the stock
- Understand what you buy, understand what we are trying to do, we are working within solid tumor environment, enormous market… great advisors…only question is how long are you willing to wait